Journal
EBIOMEDICINE
Volume 18, Issue -, Pages 118-127Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2017.03.011
Keywords
WNK4; Hypertension; Metabolic syndrome
Funding
- Japan Society for the Promotion of Science [25221306]
- Ministry of Health Labour and Welfare [1211001]
- Science Research Foundation [1026, 1228]
- Takeda Science Foundation [X2365]
- Grants-in-Aid for Scientific Research [16H01633, 17K16076, 16K09642, 17H05500, 16K15234, 17K16077, 15K19446, 15H06183, 15H06184, 15K09423, 16K15467] Funding Source: KAKEN
Ask authors/readers for more resources
The with-no-lysine kinase (WNK) 4 gene is a causative gene in pseudohypoaldosteronism type II. Although WNKs are widely expressed in the body, neither their metabolic functions nor their extrarenal role is clear. In this study, we found that WNK4 was expressed in mouse adipose tissue and 3T3-L1 adipocytes. In mouse primary preadipocytes and in 3T3-L1 adipocytes, WNK4 was markedly induced in the early phase of adipocyte differentiation. WNK4 expression preceded the expression of key transcriptional factors PPAR gamma and C/EBP alpha. WNK4-siRNA-transfected 3T3-L1 cells and human mesenchymal stem cells showed reduced expression of PPAR gamma and C/EBP alpha and lipid accumulation. WNK4 protein affected the DNA-binding ability of C/EBP beta and thereby reduced PPAR gamma expression. In the WNK4(-/-) mice, PPAR gamma and C/EBP alpha expression were decreased in adipose tissues, and the mice exhibited partial resistance to high-fat diet-induced adiposity. These data suggest that WNK4 may be a proadipogenic factor, and offer insights into the relationship between WNKs and energy metabolism. (C) 2017 The Authors. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available